Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions

Clinical trial NCT00959933 · COMPLETED

Trial details

NCT number: NCT00959933
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2001-04-01
Primary completion: 2001-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.